Imcd Switzerland Ag, based in Switzerland, is a pharmaceutical company.
One of their notable products is FLUOROURACIL, with a corresponding US DMF Number 21774.
Remarkably, this DMF maintains an Active status since its submission on June 30, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 16, 2014, and payment made on May 20, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II